In the beginning of the 21st century, many viral infections were reported with
a significant impact on the socio-economic growth of many nations globally. Many
new strains of viruses were reported in the recent past. Passive antibody therapy
involves antibody administration against various viruses. Though vaccines are
available for many diseases, however, a longer duration is required for the development
of a vaccine for novel viruses like the COVID-19 outbreak. In such cases, passive
antibody therapy plays a major role in providing instantaneous immunity to susceptible
persons. Proofs predicted that patients receiving convalescent plasma recovered from
the disease and utilized it as a treatment without any serious antagonistic occasions. In
this manner, it may be beneficial to test the safety and adequacy of convalescent
plasma transfusion in SARS-CoV-2 contaminated patients. In this chapter, the authors
conducted a brief literature review on treatment options against novel coronavirus. This
chapter emphasized on the use of plasma therapy against novel Coronavirus and its
future perspectives.
Keywords: Antibodies, Antiviral, Convalescent plasma therapy, Coronavirus,
mAb, Remdesivir.
